RenovoRx Inc
NASDAQ:RNXT

Watchlist Manager
RenovoRx Inc Logo
RenovoRx Inc
NASDAQ:RNXT
Watchlist
Price: 0.87 USD 3.2%
Market Cap: 31.9m USD

Gross Margin
RenovoRx Inc

67.8%
Current
22%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.8%
=
Gross Profit
629k
/
Revenue
928k

Gross Margin Across Competitors

No Stocks Found

RenovoRx Inc
Glance View

Market Cap
31.9m USD
Industry
Biotechnology

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for the local treatment of solid tumors. The company is headquartered in San Jose, California and currently employs 6 full-time employees. The company went IPO on 2021-08-17. The firm is focused on developing therapies for the local treatment of solid tumors. The firm's lead product candidate RenovoGem. Its other product candidate include Renovo Trans-Arterial Micro-Perfusion (RenovoTAMP), and RenovoCath delivery system. RenovoGem, is a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath. Its therapy platform, RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) is focused on optimizing drug concentration in solid tumors using small molecule chemotherapeutics that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall to bathe these difficult-to-reach tumors in chemotherapy.

RNXT Intrinsic Value
4.45 USD
Undervaluation 80%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.8%
=
Gross Profit
629k
/
Revenue
928k
What is the Gross Margin of RenovoRx Inc?

Based on RenovoRx Inc's most recent financial statements, the company has Gross Margin of 67.8%.

Back to Top